Navigation Links
Oncology basic research director at John Theurer Cancer Center continues transplantation research
Date:1/18/2011

HACKENSACK, N.J. (December XX, 2010) Thea Friedman, M.D., associate scientist and director of oncology basic research at the John Theurer Cancer Center at Hackensack University Medical Center was recently awarded a National Cancer Institutes of Health-National Cancer Institute (NIH-NCI) RO1 research grant to improve allogeneic blood and marrow transplantation for multiple myeloma patients. The grant provides $2 million in funding over the next five years.

As part of the John Theurer Cancer Center's continued efforts to improve outcomes of blood and marrow transplantation, Dr. Friedman and her colleagues have been using a molecular technique called T cell receptor Vβ CDR3 spectratype analysis to look at T-cell repertoires for the purpose of separating the donor cells responsible for graft-versus-host disease from those mediating graft-versus-tumor responses. Once separated, Dr. Friedman and her team will come closer to "personalized" transplantation, a huge milestone for the multiple myeloma community.

"This significant funding provided by the NIH is instrumental to further our blood and marrow transplant research," said Dr. Friedman. "We look forward to the possibility of using personalized transplantation to better the lives of cancer patients in our community and around the world."

The ROI research is the original and oldest grant mechanism used by NIH. The RO1 applications are peer reviewed and only those scoring above the 15th percentile are awarded. Last year, only 25 percent of the 50,000 applications were awarded a grant.

"The John Theurer Cancer Center constantly strives to provide the medical community with the latest advancements and innovations in oncology," said Andrew L. Pecora, M.D., F.A.C.P., C.P.E., chief innovations officer and professor and vice president of cancer services, the John Theurer Cancer Center. "Dr. Friedman and her colleagues' research is just one example of our commitment to a
'/>"/>

Contact: Jaymie DeGaetano
jaymie.degaetano@widmeyer.com
646-213-7243
John Theurer Cancer Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. European Multidisciplinary Conference in Thoracic Oncology
2. Spanish Oncology to establish a new standard treatment on breast cancer at early stages
3. Professor Zvi Ram presents phase III recurrent glioblastoma survival and quality of life data from the first pivotal study of the NovoTTF-100A at 15th Annual Society for Neuro-Oncology Scientific Meeting
4. OncologyPRO: Unique portal for cancer specialists
5. Boston, Oct. 21-24: Largest international pediatric oncology conference
6. Grant will aid creation of interdisciplinary oncology palliative care education program
7. Elsevier and International Society of Geriatric Oncology launch Journal of Geriatric Oncology
8. Hematology-Oncology Associates of Northern New Jersey (HOANNJ) Joins Effort to Improve Cancer Care with Via Oncology™ Pathways
9. Space Coast Cancer Center Selects Via Oncology™ Pathways to Advance Evidence-Based Cancer Care
10. Peace of Mind Skin Care Announces new Services in Oncology Esthetics
11. Christiana Care Health Systems Darcy Burbage Receives Oncology Nursing Society Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... Ohio (PRWEB) , ... August 04, 2015 , ... ... have up-to-date immunizations, especially those entering kindergarten. All required immunizations are covered for ... rules, which means that children who aren’t caught up with their immunizations may ...
(Date:8/4/2015)... ... August 04, 2015 , ... NutraScience Labs , ... fulfillment services, joined over 200 other Long Island-based corporations as participants in the ... 28th at Jones Beach State Park in Wantagh, New York. , According to ...
(Date:8/4/2015)... ... August 04, 2015 , ... Mesothelioma researchers in Australia have ... may be a viable option. Surviving Mesothelioma has just posted an article on ... surgeons at the University of New South Wales, peritoneal mesothelioma patients ...
(Date:8/4/2015)... ... 2015 , ... Providigm, LLC, a developer of quality management ... of the Advanced level of their national accreditation for Quality Assurance and Performance ... , introduced in 2013, is based on standards for excellence in continuously improving ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... Channel Report, finds the North America IT reseller channel will grow at least ... rates ahead of their 2014 pace and greater than their OEM/vendor partners. ...
Breaking Medicine News(10 mins):Health News:Buckeye Health Plan Reminds Parents to Keep Immunizations In Mind As School Year Kicks Off 2Health News:NutraScience Labs "Steps Up" to the 2015 Marcum Workplace Challenge 2Health News:New Research Reveals Some Patients Experience Extended Mesothelioma Survival with Repeat Treatment, According to Surviving Mesothelioma 2Health News:Nursing Homes Achieving New Advanced Accreditation See Improved Measures of Quality, Better Occupancy Rates 2Health News:Nursing Homes Achieving New Advanced Accreditation See Improved Measures of Quality, Better Occupancy Rates 3Health News:The 2112 Group Forecasts North America IT Channel to Grow At Least 6% in 2015 2Health News:The 2112 Group Forecasts North America IT Channel to Grow At Least 6% in 2015 3
... -- People with Parkinson,s disease appear to be at ... greater risk may extend to their close and distant ... School of Medicine researchers discovered the possible connection after ... contains birth, death and family relationship data for more ...
... that the United States begin to live within its means and ... nation we need to be smart about how we do it. ... it means for America,s future jeopardizes the very future we want ... century, science and technology have been the primary drivers of job ...
... -- Nearly one-fifth of U.S. college students who took part ... of them mistakenly believe that hookah smoking is safer than ... sample of students at eight North Carolina colleges and universities ... a hookah, nearly as many students (46.6 percent) who said ...
... 8 (HealthDay News) -- All exercise is the same, right? ... of Scotland that found that high-intensity exercise may be better ... be done in less time. The study included 57 ... assigned to high-intensity or moderate-intensity exercise groups. Both groups ...
... By Dennis Thompson HealthDay Reporter , FRIDAY, April ... problems were those of a typical teenage girl. The 16-year-old ... grumpy. Teenage stuff. Except she also felt sick, like she ... morning before she went to school. And she had shingles. ...
... Mozes HealthDay Reporter , THURSDAY, April 7 (HealthDay ... in her struggle to maintain a healthy weight. "The ... things worse, as after finishing the diet I put the ... driver from the Wurzburg region of Germany. "So, I researched ...
Cached Medicine News:Health News:Parkinson's May Have Links to Certain Cancers, Study Suggests 2Health News:US House budget plans would jeopardize scientific research facilities 2Health News:Hookah Use Common Among College Students, Survey Finds 2Health News:Short Bursts of Exercise Good for the Heart: Study 2Health News:Coping With Graves' Disease Lasts a Lifetime 2Health News:Coping With Graves' Disease Lasts a Lifetime 3Health News:Could Stomach 'Pacemaker' Be New Weight-Loss Tool? 2Health News:Could Stomach 'Pacemaker' Be New Weight-Loss Tool? 3Health News:Could Stomach 'Pacemaker' Be New Weight-Loss Tool? 4
(Date:8/3/2015)... , Aug. 4, 2015   The Intellectual ... the world,s leading provider of intelligent information for ... 2015 CMR Pharmaceutical R&D Factbook , the ... Despite concerns around declines in R&D, the analysis ... $1 trillion milestone and forecasts sales to reach ...
(Date:8/3/2015)... (NASDAQ: LMNX ) today announced financial results for ... operating highlights for the quarter include the following: ... percent to $58.9 million, over the second quarter of ... by 22 percent to $24.2 million over results from ... 2015 royalty revenue by 17 percent to $11.1 million ...
(Date:8/3/2015)... -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX ), a ... of innovative therapies for the treatment of acute pain, ... for the three and six months ended June 30, ... July 23, 2015, the Committee for Medicinal Products for ... for the management of acute moderate-to-severe post-operative pain in ...
Breaking Medicine Technology:Pharma Sales to Grow Beyond $1 Trillion 2Luminex Corporation Reports Record 2nd Quarter 2015 Results 2Luminex Corporation Reports Record 2nd Quarter 2015 Results 3Luminex Corporation Reports Record 2nd Quarter 2015 Results 4Luminex Corporation Reports Record 2nd Quarter 2015 Results 5Luminex Corporation Reports Record 2nd Quarter 2015 Results 6Luminex Corporation Reports Record 2nd Quarter 2015 Results 7Luminex Corporation Reports Record 2nd Quarter 2015 Results 8Luminex Corporation Reports Record 2nd Quarter 2015 Results 9Luminex Corporation Reports Record 2nd Quarter 2015 Results 10Luminex Corporation Reports Record 2nd Quarter 2015 Results 11Luminex Corporation Reports Record 2nd Quarter 2015 Results 12Luminex Corporation Reports Record 2nd Quarter 2015 Results 13Luminex Corporation Reports Record 2nd Quarter 2015 Results 14Luminex Corporation Reports Record 2nd Quarter 2015 Results 15Luminex Corporation Reports Record 2nd Quarter 2015 Results 16AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 2AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 3AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 4AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 5AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 6AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 7AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 8AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 9AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 10
... and Progressive Form of Inflammatory Spinal Arthritis Receiving Monthly Golimumab ... ... BOSTON, Nov. 7 More than half of patients receiving,monthly ... experienced significant and sustained improvements in the signs and,symptoms of active ...
... of Trial Volunteers Must Remain Paramount Concern, SEATTLE, ... the following statement today from Executive,Director Mitchell Warren in ... AIDS vaccine study by Merck & Co., the US ... HIV Vaccine Trials Network,(HVTN) at a public forum at ...
Cached Medicine Technology:New Anti-TNF Golimumab Significantly Reduced Signs and Symptoms of Ankylosing Spondylitis According to Phase 3 Study Findings 2New Anti-TNF Golimumab Significantly Reduced Signs and Symptoms of Ankylosing Spondylitis According to Phase 3 Study Findings 3New Anti-TNF Golimumab Significantly Reduced Signs and Symptoms of Ankylosing Spondylitis According to Phase 3 Study Findings 4New Anti-TNF Golimumab Significantly Reduced Signs and Symptoms of Ankylosing Spondylitis According to Phase 3 Study Findings 5New Anti-TNF Golimumab Significantly Reduced Signs and Symptoms of Ankylosing Spondylitis According to Phase 3 Study Findings 6New Anti-TNF Golimumab Significantly Reduced Signs and Symptoms of Ankylosing Spondylitis According to Phase 3 Study Findings 7AIDS Vaccine Advocacy Coalition Calls for AIDS Vaccine Field to Work Together to Analyze STEP Study Data and Determine Best Course to Move Forward 2AIDS Vaccine Advocacy Coalition Calls for AIDS Vaccine Field to Work Together to Analyze STEP Study Data and Determine Best Course to Move Forward 3
... Dual Power is a microprocessor-controlled programmable ... high voltage/low current and high current/low ... current section is ideal for sample ... sequencing applications. The low voltage/high current ...
... These modified battery ... power supplies for GENIE ... to produce very specific ... reproducibility than laboratory power ...
Inquire...
... Power Supply . The digital 200 V/2000 ... 2 A in 1 volt and 10 mA ... to three SEA 2000® apparatus simultaneously at 55°C. ... actual values of voltage, current and time • ...
Medicine Products: